Tuesday, 18 September 2018

Synthetic Fibers Market to Surpass $88.5 Billion by 2025: Grand View Research Inc.

San Francisco, 18 September 2018: According to a report by Grand View Research, Inc., global synthetic fibers market is projected to value USD 88.5 billion by 2025. Growing requirement for durable and cost-effective raw materials is anticipated to propel demand for synthetic fibers. Such fibers can be derived from polymers and known as man-made fibers. They can possess highly useful properties as raw material such as light weight, elasticity, moisture resistance, wrinkle resistance, and strength. Growing need for materials among manufacturers can fuel product demand during the forecast period (2014-2025).

Increasing use of synthetic fibers in automotive interior materials coupled with growing demand for hybrid and electric vehicles can spur market growth. High demand for home furnishings owing to increasing number of population migrating to urban areas is expected to fuel growth of market in the forthcoming years. Growing adoption of attractive and high-value clothes due to expanding e-commerce business can influence market growth. Stringent regulations on environmental protection is anticipated to hinder growth of market owing to non-biodegradability of synthetic fibers.

Access Research Report of Synthetic Fibers Market@ www.grandviewresearch.com/industry-analysis/synthetic-fibers-market

The synthetic fibers market can be segregated on the basis of product type, application, and region. Based on product type, the market can be classified into nylon, polyester, acrylics, polyolefin, and others. Growing adoption of polyester to manufacture clothes owing to its effective properties such as chemical and abrasion resistance can fuel its demand. In addition, affordability of polyester to cater to increasing number middle class population in emerging economies is one of the biggest factors contributing to market growth. Asia Pacific region is expected to lead in both production and consumption of polyester and can maintain this lead during the forecast period too. The nylon segment is expected to grow well in the coming years owing to its scope in a wide range of applications such as tents, seat belts, airbags, ropes, and sleeping bags.

Based on application, the market can be divided into home furnishing, clothing, automotive, filtration, and others. In 2016, the clothing segment dominated the market and accounted for 45.48% of global revenue share. Rising number of consumers preferring clothes which are easy to maintain can spur product demand. In addition, high consumer demand for clothes offering advanced protection and convenience owing to hectic lifestyles can further stimulate product demand. Provision of such essential features in clothes manufactured from synthetic polymers is anticipated to boost segment demand in the coming years. Moreover, wide scope of development for clothing industry in growing economies such as India and China can also influence demand for synthetic fibers. The growing number of infrastructural activities in China and India is expected to propel growth of home furnishing segment. In addition, launch of innovative schemes from local governments such as Make in India and Smart City Plans can further encourage growth.  

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/renewable-chemicals

Regional segmentation includes Asia Pacific, North America, Europe, Central & South America, and Middle East & Africa. In 2016, Asia Pacific dominated the market and accounted for revenue share equivalent to USD 34,765.2 million. It is estimated to grow at a phenomenal CAGR of 7% from 2017 to 2025 owing to increasing number of applications such as home furnishing, automotive, clothing, and filtration in the region. Growth of these applications in this region can fuel product demand in the forthcoming years.

North America stood second in terms of revenue share in 2016 and accounted for 12.51% of market share in the same year. It is likely to grow at a similar pace during the forecast period. Fast growth of multiple industries such as automotive, clothing, and home furnishing utilizing synthetic fiber as a raw material can augment product demand in the region.  

Some of the leading companies offering synthetic fibers are Reliance Industries Limited, Lenzing AG, Mitsubishi Chemical Holdings Corporation, Indorama Corporation, and China Petroleum Corporation (CPEC). Most companies are likely to invest in R&D activities to develop specific synthetic fibers for better use in multiple applications. Growing adoption of backward integration of the supply chain by major players is likely to obstruct entry of new and aspiring players.

Access Press Release of Synthetic Fibers Market@ www.grandviewresearch.com/press-release/global-synthetic-fibers-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Smart Pills Market Poised for Robust Value CAGR of Over 15.5% Through 2025: Grand View Research Inc.

San Francisco, 18 September 2018: According to a research report published by Grand View Research, Inc.; the smart pills market likely to reach a valuation of around USD 3.0 billion by 2025. The market is estimated to register a healthy growth rate of 15.5 % during the forecast period (from 2018 to 2025). High prevalence of gastrointestinal disorders and colorectal cancer is one of the primary factors responsible for the increased demand for smart pills. Moreover, rise in cancer screening awareness programs and increasing FDA approvals are also considered as the major factors driving the market growth.

Smart pills are mainly used for screening and treatment of various diseases including colorectal cancer, gastroparesis, gastric ulcers, gastroesophageal disorders. They also find applications in the treatment of several GI-related diseases including Crohn’s disease, celiac disease, small bowel tumors, and obscure GI bleed. These pills provide non-invasive and accurate visualization of the distal duodenum, small bowel, jejunum, colon, ileum, and gastrointestinal.

Increasing demand for minimally invasive surgical procedures have encourage the development of innovative methods like capsule endoscopy. This is likely to replace the traditional method of endoscopy, thereby driving the smart pills market growth in the next few years. In addition, patients suffering from chronic diseases require a particular dose of medicines at target place. This is also anticipated to create a large consumer base for advanced drug delivery aids, thereby augmenting the market growth.

Access Research Report of Smart Pills Market@ www.grandviewresearch.com/industry-analysis/smart-pills-market

Demand for advanced drug delivery systems with benefits including optimal use of active pharmaceutical constituent, negligible side effects, reduced dosage frequency, and harmless carrier is also likely to fuel product demand. Worldwide smart pills market is segmented into application and region. Based on application, the market is categorized into product, tools, and patient monitoring software. Geographically, the market is divided into North America; Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA).

In 2016, North America accounted for the largest revenue share of 57.1 % and dominated the global market in the past. It is expected to maintain its dominance even during the forecast period. Factors such as growing government expenditure for healthcare, favorable reimbursement policies, and technological progressions are projected to be the major drivers for the region’s expansion. In addition, mandatory healthcare insurance, rising cases of colorectal cancer, and approvals for newer products are also likely to propel the market development in the region.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Asia Pacific is likely to witness the fastest growth over the next few years. Emerging countries in this region such as India, Japan, and China are expected to drive the product demand. Among these Asian countries, Japan stands on third position in stomach cancer cases, according to the World Cancer Research Fund International. Rapidly expanding Japanese market is mainly driven by high prevalence of stomach cancer and cases of gastrointestinal complaints. Moreover, growing government support and technological developments would also spur the regional expansion.

Some of the leading companies operating in the global market for smart pills include CapsoVision, Inc.; Olympus Corporation; Medtronic PLC; MediSafe; and Proteus Digital Health. Most of these major market participants are mainly focusing on upgrading their products. The new participants focus on developing more advanced and affordable products. For instance, Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) recently declared that they received an approval from the US Food and Drug Administration (FDA) for their digital medicine system called ABILIFY MYCITE. It is a drug-device combination product that contains Otsuka’s oral aripiprazole tablets implanted with an Ingestible Event Marker (IEM) sensor.

ABILIFY MYCITE is designed to track drug ingestion. The new ABILIFY MYCITE is an atypical antipsychotic and is indicated in adults to treat schizophrenia and acute manic and mixed episodes and for maintaining the treatment of bipolar I disorder as monotherapy and as adjunctive therapy to lithium or valproate. However, it is recommended not to use the new product to track drug ingestion in real-time or during an emergency as detection may be delayed or may not occur.

Access Press Release of Smart Pills Market@ www.grandviewresearch.com/press-release/global-smart-pills-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

SLE Market to Reflect Robust Expansion During 2018- 2025: Grand View Research Inc.

San Francisco, 18 September 2018: The global systemic lupus erythematosus market size is expected to reach USD 3.08 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.0% during the forecast period.Introduction of new biological therapies, which will add to treatment alternatives and medication costs, in the development pipeline is estimated to fuel revenue generation of the market. Certain new promising drugs that are currently in Phase III trials are anticipated to augment the market as these drugs may target the lupus nephritis patient subset with few effective alternatives and significant unmet needs to be met. This factor is likely to have a strong impact on the market as nearly 50.0% of SLE patients suffer with lupus nephritis.

Use of approved biologic, Benlysta, through clinical studies, has revealed drastic improvements and substantial decrease in consumption of anti-inflammatory glucocorticoids in moderate SLE cases. GSK’s current initiatives center on further increasing opportunities for Benlysta. The company is conducting indication expansion clinical trials, combination therapy studies with rituximab, and new product development, to widen opportunities for its therapy. In this direction, recent launch of Benlysta’s subcutaneous formulation in several countries is expected to boost the SLE market over the forecast period.

Further key findings from the study suggest:
·        North America was the major contributor for the SLE market revenue in 2017 and is anticipated to rise at a CAGR of 8.1% during the forecast period. This is due to availability of reimbursement and better healthcare infrastructure and accessibility to biologics.
·       Europe was ranked as the second largest regional market in the SLE market in 2017 and is expected to register a CAGR of 5.5% over the forecast period
·        Immunosuppressants held the largest share in the market in 2017 due to their low cost and high accessibility, whereas the biologics segment is projected to post the highest CAGR during the same period
·       In 2017, the oral segment held the dominant share of over 54.0% in the market, followed by the intravenous segment that requires trained medical personnel for administration. Over the forecast years, the latter is poised to expand at a CAGR of 10.4%
·       Key players in this space include GlaxoSmithKline, Roche, Pfizer, Novartis, Bayer, and Sanofi. By 2025, other companies such as ImmuPharma, Aurinia Pharmaceuticals, and Astra Zeneca are anticipated to enter the SLE market.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global systemic lupus erythematosus market by drug class, route of administration, and region:
Systemic Lupus Erythematosus Drug Classes Outlook (Revenue, USD Million, 2014 - 2025)
·         NSAIDs
·         Corticosteroids
·         Antimalarials
·         Immunosuppressants
·         Biologics
Systemic Lupus Erythematosus Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)
·         Oral
·         Intravenous
·         Subcutaneous
Systemic Lupus Erythematosus Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    U.K.
o    Germany
o    France
o    Italy
o    Spain
o    Greece
o    Sweden
o    Norway
o    Poland
o    RoE
·         Asia Pacific
o    Japan
o    China
o    Hong Kong
o    Taiwan
o    South Korea
o    New Zealand
o    Australia
o    India
o    Malaysia
o    Singapore
·         Latin America
o    Brazil
o    Mexico
o    Argentina
·         MEA
o    Turkey
o    Saudi Arabia
o    Kuwait
o    Israel
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Monday, 17 September 2018

Kombucha Market to Witness Exponential Growth by 2025: Grand View Research Inc.

San Francisco, 18 September 2018: The global kombucha market size is projected to reach USD 5.45 billion by 2025, according to a new report by Grand View Research, Inc. It is likely to expand at a CAGR of 23.0% over the forecast period. This market is anticipated to be driven by innovations, flavor experimentation, and increasing awareness regarding health benefits associated with kombucha consumption.

The market is primarily expected to grow on account of accelerating rate of consumption of kombucha as an alternative to aerated drinks and beverages. This market is luring international aerated drinks manufacturers to invest in and acquire emerging players.
Distinguishing factor that provides a competitive edge for this market is that kombucha is home-made and has a wide potential for experimentation. Beverage manufacturing companies are exhibiting trends like organizing kombucha tasting competition giving anopportunity to kombucha makers to come and showcase their product. Winner of the competitions is heavily funded by established players. This trend is showcasing excellent capital potential.
Kombucha market value chain comprises raw material suppliers, manufacturers, distributors, and end-use verticals. Kombucha is derived from raw materials such as tea leaves, Symbiotic Colony of Bacteria and Yeast (SCOBY), sugar, and flavors.
Application areas of kombucha are widening in other segments of food and beverage such as breakfast meals, ice cream toppings, and candies among others. This is also projected to generate future market opportunities.
Access Research Report of Kombucha Market@ www.grandviewresearch.com/industry-analysis/kombucha-market

Further key findings from the report suggest:
·       The global consumption for kombucha was estimated to be 82,960.9 kilo liters in 2016
·       In 2016, kombucha consumption in U.K.was estimated to be 2,930.9 kilo liters and is estimated to reach 27,803.9 kilo liters by 2025
·       Revenue from online stores in Russia was estimated to be USD 14.25 million in 2016. This segment is estimated to grow at a CAGR of 23.1% in this region during the forecasted period
·       Established aerated beverage producers are heavily investing in kombucha manufacturing companies therefore bringing in positive investment environment in this market
·       In 2016, PepsiCo ventured into the kombucha market by acquiring Ke-Vita, a kombucha manufacturing giant.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements
Grand View Research has segmented the global kombucha market on the basis of flavor, distribution channel, and region:
Kombucha Flavor Outlook (Volume, Kilo Liters; Revenue, USD Million, 2014 - 2025)
·         Original
·         Flavored
Kombucha Distribution Channel Outlook (Volume, Kilo Liters; Revenue, USD Million, 2014 - 2025)
·         Supermarkets
·         Online Stores
·         Health Stores
Kombucha Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    Germany
o    U.K.
o    France
o    Russia
·         Asia Pacific
o    China
o    India
o    Japan
o    Australia
·         Central & South America
o    Brazil
·         Middle East & Africa
o    South Africa
Access Press Release of Kombucha Market@ www.grandviewresearch.com/press-release/global-kombucha-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

License Management Market Size, Trends, and Growth Forecast 2033

  License management is the process of tracking, organizing, and controlling software licenses within an organization. As businesses increas...